How to Source Rabeprazole /Domperidone Tablets for Pharmaceutical Formulation
Rabeprazole /Domperidone Tablets (Tablets, 20mg+30mg) is classified under Gastrointestinal Drugs. It is therapeutically aligned with reference brands such as Rabicip-D (India), Rabez-D. This guide highlights key sourcing factors buyers should consider when procuring high-quality Rabeprazole /Domperidone Tablets for formulation, R&D, or bulk manufacturing.
Product Overview:
Domperidone+Rabeprazole is a combination medicine used to treat gastroesophageal reflux disease (Acid reflux) and peptic ulcer disease by relieving the symptoms of acidity such as heartburn, stomach pain, or irritation. It also neutralizes the acid and promotes easy passage of gas to reduce stomach discomfort.
Rabeprazole / Domperidone is a commonly prescribed combination medication used for the effective man...
Rabeprazole /Domperidone Tablets API – ideal for compliant pharmaceutical formulation.
Quick Insight: Over 60% of formulation delays are linked to poor API sourcing. A well-planned sourcing strategy can reduce risk and accelerate market entry.
1. Regulatory Compliance & Documentation
Ensure suppliers provide:
- ✔ Valid DMF (Drug Master File)
- ✔ COA (Certificate of Analysis) for each batch
- ✔ GMP, ISO, or ICH Q7 compliance certificates
2. Purity, Grade & Specification Matching
Rabeprazole /Domperidone Tablets must meet exact grade and purity for your dosage form:
- ✔ USP / EP / JP grade verification
- ✔ Particle size distribution check
- ✔ Residual solvent and heavy metal limits
3. Supplier Reliability & Audit History
- ✔ Positive past audit reports
- ✔ Pharma client references
- ✔ Years of proven API manufacturing experience
4. Commercial Terms: Pricing, MOQ & Flexibility
- ✔ Transparent pricing
- ✔ Pilot batch MOQ flexibility
- ✔ Volume-based discounts
5. Lead Time, Inventory & Logistics
Typical lead time for Rabeprazole /Domperidone Tablets is 4–6 weeks.
- ✔ Emergency dispatch options
- ✔ Regional warehousing
- ✔ Special storage if needed
6. Formulation Support
- ✔ Technical datasheets
- ✔ Sample availability
- ✔ Stability study support
Pro Tip: Engage supplier formulation experts early — it can improve bioavailability and cut development time.
Conclusion
Sourcing Rabeprazole /Domperidone Tablets is more than procurement—it’s a strategic partnership. With its tablets form and 20mg+30mg specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.
Next Step: Get expert assistance in sourcing Rabeprazole /Domperidone Tablets.
Request a Quote
Frequently Asked Questions For Sourcing of Rabeprazole /Domperidone Tablets
What is the typical lead time for Rabeprazole /Domperidone Tablets?
Lead times range from 4–6 weeks depending on supplier and region.
Is Rabeprazole /Domperidone Tablets available in multiple grades?
Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.
Does Rabeprazole /Domperidone Tablets require special storage?
It should be stored in a cool, dry place away from direct sunlight.
Is a Drug Master File (DMF) available for Rabeprazole /Domperidone Tablets?
Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.
Can I request samples or a pilot batch of Rabeprazole /Domperidone Tablets?
Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.
What compliance certificates are available for Rabeprazole /Domperidone Tablets?
Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.
Is Rabeprazole /Domperidone Tablets suitable for regulated markets like US/EU?
Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.
Can Rabeprazole /Domperidone Tablets be used in fixed-dose combinations?
Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our
Privacy Policy.